Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.0B | 14.2B | 13.3B | 12.9B |
Cost of revenue | 8.0B | 7.6B | 8.1B | 7.0B |
Gross profit | 7.0B | 6.6B | 5.2B | 5.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | 3.1B | -6.3B | 2.5B |
Operating income | 3.2B | 2.8B | 3.5B | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26.2M | 23.3M | 26.8M | 20.3M |
Other income expense | — | — | — | — |
Pretax income | 3.3B | 3.1B | 3.7B | 2.8B |
Tax provision | 855.4M | 792.6M | 995.4M | 730.3M |
Net income | 2.4B | 2.3B | 2.7B | 2.1B |
Basic EPS | 2.5 | 2.4 | — | 2.1 |
Diluted EPS | 2.5 | 2.4 | — | 2.1 |
Basic average shares | 987.9M | 989.2M | — | 987.8M |
Diluted average shares | 987.9M | 989.2M | — | 987.8M |
EBITDA | 3.3B | 3.2B | 3.7B | 2.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |